Availity to Acquire Utilization Management Solution and Business Unit from Olive

Game-changing investment in transformative artificial intelligence technology aligns with Availity’s vision for intelligent and fully automated authorizations between health plans and providers

Availity, one of the nation’s largest real-time health information networks, announced a definitive agreement to acquire the utilization management solution and business unit from healthcare automation company Olive AI, Inc. This transaction also includes assuming the commercial contract with Olive’s current utilization management customers and hiring key associates dedicated to the utilization management business.

The acquisition strengthens Availity’s existing strategy to deliver an automated solution for end-to-end authorization transactions, which today remains driven largely by expensive, resource-intensive manual processes.

“We saw a clear opportunity to acquire an automated, digital solution to one of the costliest and most manually driven workflows in healthcare—authorizations,” said Russ Thomas, CEO of Availity. “This technology perfectly aligns with Availity’s vision of delivering omni-channel, multi-payer solutions to a fragmented healthcare data ecosystem. This game-changing solution will help our provider and health plan customers overcome the common barriers to ensuring timely care delivery, resource allocation, and patient satisfaction.”

Authorizations were created to optimize care paths and manage costs. However, Availity’s market research indicates that payers and providers collectively spend up to $13 billion every year managing an administrative process widely blamed for care delays, patient dissatisfaction, staff burnout, and friction between payers and providers.

To date, automation of authorizations has been difficult because they require both administrative and clinical data, which are often stored in siloed information systems and in non-standardized formats that require manual intervention to bring together. Availity’s AI auth solution leverages automation capabilities and Natural Language Processing (NLP) to streamline authorizations workflow, including:

  • Importing and structuring payers’ medical policies to automatically approve authorizations based on the codified medical policies.
  • Front-end capabilities that enable providers to simplify authorizations workflow.
  • Clinical data collection is automated and standardized, eliminating the multiple steps and handoffs in a manual workflow.
  • Reducing authorization approval time from days to seconds.

As a result, payers and providers can enjoy the benefits of lower administrative and medical costs, improved patient access and experience, and clinical data for making enhanced and strategic business decisions.

Availity Authorizations at HIMSS23

Learn more about the vision behind Availity’s AI auth solution at HIMSS23, April 17-21, in Chicago. Visit Availity at Booth 8336 or Meeting Place MP2284.

Transaction Details

The transaction is subject to customary closing conditions and is expected to be completed in the coming weeks. Additional details regarding the transaction were not disclosed.

SourceAvaility

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version